Innovative Lung-on-a-Chip with Immune Function Mimics a Living Organ

A pioneering lung-on-a-chip with an active immune system offers new insights into lung disease, infection response, and personalized therapies, transforming preclinical research and reducing animal testing.
Researchers at Georgia Tech and Vanderbilt University have developed a groundbreaking lung-on-a-chip that integrates a functional immune system, marking a significant advancement in biomedical engineering. This miniature model of the human lung, constructed on a flexible polymer chip, simulates the organ’s natural behavior, including expansion, blood circulation, and immune responses. Unlike previous models, this innovative platform enables scientists to observe immune cell movement and response within lung tissue, providing deeper insights into how the lungs combat infections and inflammatory diseases.
The development was led by Ankur Singh, director of Georgia Tech's Center for Immunoengineering, who described witnessing immune cells actively migrating through the chip as a transformative moment. Alongside Krishnendu Roy and colleagues, Singh’s team faced the challenge of maintaining viable immune cells within the chip, a hurdle they successfully overcame, resulting in a model where immune responses to pathogens like influenza could be closely studied.
This model not only responds accurately to infections but also offers a more human-relevant alternative to traditional animal testing, which often fails to fully replicate human lung responses. Singh emphasized the importance of this technology for understanding severe viral infections and developing effective treatments. The platform holds promise for studying other lung diseases such as asthma, cystic fibrosis, and lung cancer, and aims toward personalized medicine by creating patient-specific chips.
This innovation could revolutionize the way respiratory diseases are researched, allowing for better prediction of treatment efficacy and reducing reliance on animal models. It exemplifies a significant step toward more accurate, human-relevant preclinical testing and could ultimately lead to improved therapies and outcomes for millions suffering from lung ailments.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Blood Test Uses Immune Protein Changes for Early Tumor Detection and Personalized Treatment Guidance
A new blood test developed by CNIO detects early-stage tumors by analyzing immune protein changes in blood, offering a promising tool for early diagnosis and personalized treatment guidance.
Alcohol Withdrawal Therapy Promotes Positive Changes in Gut Microbiome
Alcohol withdrawal therapy induces positive changes in the gut microbiome, reducing cravings and inflammation, and offering new therapeutic approaches for alcohol use disorder.
Key Gene Expression Disruption Central to ALS Development Unveiled
A groundbreaking study uncovers the central role of UNC13A gene regulation in ALS development, revealing shared molecular pathways that could guide new treatments for this devastating disease.



